Sharps Technology Signs Asset Purchase Agreement to Acquire InjectEZ Specialty Copolymer Syringe Manufacturing Facility and a 10-Year Purchase Agreement for Over $400 Million from Nephron Pharmaceuticals
26 sept. 2023 08h30 HE
|
Sharps Technology Inc
Sharps Technology Signs Asset Purchase Agreement to Acquire InjectEZ for $50M and 10-Year Purchase Agreement for Over $400 Million from Nephron
Sharps Technology Appoints Industry Sales and Manufacturing Leader Ben Scheu as Senior Director of Sales
12 juil. 2023 08h33 HE
|
Sharps Technology Inc
Key appointment with demonstrated experience in leading sales and marketing operations to oversee commercial initiatives as the Company launches its specialty smart safety syringe products to the...
Sharps Technology Provides Update on Commercialization Activities and is Highlighted in Med Tech Outlook Feature Article
06 juil. 2023 07h50 HE
|
Sharps Technology Inc
Company advances commercialization of Securegard smart safety syringe product linethrough qualification programs with a major medical device company Production of prefilled syringe products will...
Sharps Technology Issues Update Letter to Shareholders from CEO Robert Hayes
04 avr. 2023 08h00 HE
|
Sharps Technology Inc
Commercial revenue from specialty safety syringe systems is advancing Company to launch its vial draw syringe systems in Q2 2023Launch of high-value, next-generation polymer-based products expected in...
Sharps Technology Appoints Justin Page as Vice President of Technical Operations
09 févr. 2023 09h21 HE
|
Sharps Technology Inc
NEW YORK, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company offering patented,...
Sharps Technology Announces Closing of $3.8 Million Private Placement Priced At-the-Market
06 févr. 2023 09h02 HE
|
Sharps Technology Inc
NEW YORK, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company offering patented,...
Sharps Technology Announces Pricing of $3.8 Million Private Placement Priced at the Market
01 févr. 2023 09h20 HE
|
Sharps Technology Inc
NEW YORK, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company offering patented,...
Sharps Technology Ships First Containers of Safety Syringes to Nephron Pharmaceuticals for Commercialization
31 janv. 2023 08h00 HE
|
Sharps Technology Inc
First product shipped from Sharps' facility in Hungary and first to support the Nephron Pharmaceuticals distribution and sales collaboration Sharps anticipates 1.3 million units to be...
Sharps Technology Inc. to Introduce New Specialized Prefillable Syringe Systems in 2023
10 janv. 2023 08h00 HE
|
Sharps Technology Inc
High-Value specialized prefillable syringe systems to accelerate revenue growth in 2023 and beyond Company to launch next generation specialty polymer-based syringe products for the healthcare market...
Sharps Technology Begins Manufacturing at its Hungary Facility for the Company's Innovative Syringe Products
20 déc. 2022 08h00 HE
|
Sharps Technology Inc
Company now transitions from a pre-revenue research & development start-up to a revenue generating manufacturing company Shipments to commence by the end of the year to support the recently...